EWM
DNLI icon

Empirical Wealth Management’s Denali Therapeutics DNLI Stock Holding History

Empirical Wealth Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,033
Closed -$267K – 474
2023
Q2 		$267K Buy
+9,033
New +$254K 0.01% 389

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Empirical Wealth Management's DNLI Position: Q3 2023 in Review

Empirical Wealth Management sold out of Denali Therapeutics (DNLI) in Q3 2023, closing a stake of 9,033 shares — an estimated $267K sold.

Empirical Wealth Management first reported a position in DNLI in Q2 2023 and held it in 1 quarter. The position peaked at $267K in Q2 2023. 194 funds tracked by Wall St. Rank hold DNLI as of Q3 2023.

  • Empirical Wealth Management reported no remaining Denali Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Empirical Wealth Management sold 9,033 Denali Therapeutics shares in Q3 2023, an estimated $267K.
  • Empirical Wealth Management first reported a position in Denali Therapeutics in Q2 2023 and held it in 1 quarter.
  • Empirical Wealth Management's Denali Therapeutics position peaked at $267K in Q2 2023.
  • 194 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2023.

Based on Empirical Wealth Management's 13F filing for Q3 2023, filed 3 Nov 2023.